鼻窦鳞状细胞癌中p16与人乳头瘤病毒的关系
Human papillomavirus (HPV) in oropharyngeal squamous cell carcinoma (SCC) is a well-known cause and prognostic indicator, and the utility of p16 as a surrogate marker for HPV status has been established.…
核心结论
- p16阳性及HPV阳性鼻窦鳞癌患者生存改善,且p16与HPV状态正相关。
关键数值与推荐
- p16免疫组化及HPV RNA原位杂交用于状态判定。
临床怎么用
- 对鼻窦鳞癌可检测p16和HPV状态以辅助预后分层。
- p16阳性或HPV阳性提示可能较好生存,或可参考口咽癌分类模式。
局限性
- 为单中心回顾性研究,结论需外部验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Human papillomavirus (HPV) in oropharyngeal squamous cell carcinoma (SCC) is a well-known cause and prognostic indicator, and the utility of p16 as a surrogate marker for HPV status has been established. P16 and its relationship with HPV have not been defined in sinonasal malignancy nor has a link with outcomes been established. Patients with sinonasal SCC from 2011 to 2017 were identified from our pathology database. P16 immunohistochemistry and HPV RNA in situ hybridization were performed on tissue specimens. Forty-seven patients were included. Disease-free survival for p16+ patients was significantly higher than p16- patients (P = .043). Fewer HPV+ patients died (P = .052) or experienced recurrence (P = .0437). Odds ratio between p16 and HPV status was 14.19 (95% CI: 1.72, 442.03). Our findings demonstrate improved survival in both the p16+ and HPV+ groups and a positive association between p16 and HPV. There may be similar potential for modifying classification for HPV+ sinonasal SCC.
引用
- Cohen E, Coviello C, Menaker S, et al. P16 and human papillomavirus in sinonasal squamous cell carcinoma. Head Neck. 2020. PMID: 32149447. doi:10.1002/hed.26134
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。